Core Insights - Tempus AI and NVIDIA are both making significant strides in the AI and healthcare sectors, with Tempus AI focusing on precision oncology and NVIDIA leading in AI infrastructure [2][3] - Year-to-date, Tempus AI shares have increased by 91.8%, outperforming NVIDIA's 29.2% gain, indicating strong investor confidence in Tempus AI's growth potential [4] Tempus AI Performance - Tempus AI reported a 75% year-over-year revenue growth in Q1 2025, driven by an 89% increase in genomics revenues and a 31% growth in oncology testing [5][9] - The company is transitioning from diagnostics to developing large-scale AI models, highlighted by a $200 million partnership with AstraZeneca and Pathos to create a significant oncology foundation model [6][9] NVIDIA's Healthcare Initiatives - NVIDIA is enhancing its health tech presence through platforms like Clara and BioNeMo, and partnerships with companies like Novo Nordisk and DCAI to accelerate drug discovery [10][12] - The company is addressing healthcare challenges in Europe by deploying AI solutions to improve patient care and operational efficiency [12] Valuation Comparison - Tempus AI has a forward price-to-sales (P/S) ratio of 7.84, which is below its one-year median of 8.11, while NVIDIA's ratio is 18.96, above its median of 17.81, indicating Tempus AI may be more attractively valued [13] - Analysts suggest a 5.3% upside for Tempus AI based on short-term price targets, compared to a 5.1% upside for NVIDIA [14][16] Final Assessment - Both companies hold a Zacks Rank 3 (Hold), but Tempus AI shows stronger year-to-date gains, faster revenue growth, and a more appealing valuation, making it a potentially better short-term investment in the AI-health tech space [18]

Group 1: Market Performance - As of July 2, 2025, the CSI Hong Kong Internet Index (931637) decreased by 0.88%, with mixed performance among constituent stocks [3] - The Hong Kong Internet ETF (159568) fell by 1.33%, with the latest price at 1.71 yuan, while it recorded a cumulative increase of 0.99% over the past week as of July 1, 2025 [3] - The Hong Kong Internet ETF had a turnover rate of 12.93% during the trading session, with a transaction volume of 41.67 million yuan, indicating active market trading [3] Group 2: Company Developments in Healthcare - Domestic companies like JD Health launched a self-developed medical model "Jingyi Qianxun" and established partnerships with over 150,000 pharmacies by Q1 2025 [4] - ByteDance entered the healthcare sector through acquisitions and established an AI drug development department [4] - Tencent introduced AI platforms for early disease screening and drug discovery, enhancing diagnostic efficiency for healthcare professionals [4] - Internationally, Google, NVIDIA, and Microsoft made significant advancements in AI tools for healthcare, including open-sourcing AI frameworks and developing clinical workflow assistants [4] Group 3: ETF Performance Metrics - The Hong Kong Internet ETF recorded a 54.80% net value increase over the past year, ranking 122 out of 2889 index funds, placing it in the top 4.22% [5] - The ETF achieved a maximum monthly return of 30.31% since inception, with a historical one-year profit probability of 100% [5] - The ETF's management fee is 0.50%, and the custody fee is 0.10%, which are among the lowest in comparable funds [5] - The latest price-to-earnings ratio (PE-TTM) for the index tracked by the ETF is 22.3, indicating a valuation below 80.75% of the time over the past year [5] Group 4: Index Composition - The CSI Hong Kong Internet Index consists of 30 listed companies related to internet businesses, reflecting the overall performance of internet-themed stocks within the Hong Kong Stock Connect [6] - As of June 30, 2025, the top ten weighted stocks in the index accounted for 72.11% of the total index weight, including major players like Xiaomi, Tencent, and Alibaba [6]

Investment Rating - The industry investment rating is "Leading the Market" which indicates a projected outperformance of over 10% relative to the benchmark index in the next 6-12 months [2][8]. Core Insights - The report highlights the gradual integration of the C-end AI medical applications industry ecosystem, driven by technological advancements and policy guidance [5]. - The AI+medical market in China is expected to grow from 8.8 billion yuan in 2023 to 315.7 billion yuan by 2033, with a compound annual growth rate (CAGR) of 43.1% over the next decade [5]. - The report emphasizes the increasing number of AI applications in the medical field, with 101 models and algorithms registered by the end of 2024, covering various areas such as consultation dialogues (48%), health assessments (24%), and diagnostic assistance (5%) [5]. - Major domestic and international tech companies are actively entering the medical sector, with notable developments from companies like JD Health, ByteDance, Tencent, Google, and Microsoft [5]. Summary by Sections Industry Performance - The report provides a performance overview indicating relative returns of 5.83% over 1 month, 6.73% over 3 months, and 38.04% over 12 months, alongside absolute returns of 8.32%, 7.98%, and 51.74% respectively [4]. Related Reports - The report references several related analyses on the media sector, including developments in AI smart glasses and the impact of domestic video generation models on industry growth [5]. Investment Recommendations - The report suggests focusing on companies such as Alibaba-W, Tencent Holdings, JD Health, Meituan-W, and Waterdrop, as they leverage technological and data advantages to drive industry growth [5].

下一个黄金赛道。 作者 I 岳笑笑 报道 I 投资界PEdaily 黄仁勋又出手了。 本周，黄仁勋现身越南，期间宣布一则消息：英伟达已收购越南医疗保健初创公司 Vi nBr a i n。 这一笔交易看似意外，却又有迹可循。今年以来，黄仁勋在多个公开场合强烈表示了对AI医疗的狂热。这一次，他买下越南明星AI医 疗大模型公司——Vi nBr a i n，成为押注AI医疗的又一注脚。如今打开Vi nBr a i n的官网，"Vi nBr a i n is now a pa rt of NVIDIA"的通知 已经出现在主页。 买了一个AI医疗团队 被黄仁勋看中，Vi nBr a i n有何来头？ 资料显示，Vi nBr a i n的创始人是St e ve n Tr u on g。他曾在人工智能和软件行业工作了26年，就职于霍尼韦尔、I n t e lliCommuniti e s等顶 级技术公司，还是微软人工智能产品平台的关键发起人。 图源官网 2019年，St e ve n Tr uong回到越南，在照顾中风的年迈母亲时，他感受到到医院过度拥挤给患者及其家人带来的不便。结合自身经 历，他产生了将AI与医疗结合创业的 ...